SEC Filings TLDR
Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process 8-K, 6-K, Schedule 13G. We will support more forms in the future.
Filter by Form Type:
2025-10-29MGY8-KMagnolia Oil & Gas Corporation Q3 2025 Earnings ReleaseearningsMEDIUM
Magnolia Oil & Gas Corporation reported its financial and operational results for the third quarter of 2025. The company achieved a net income of $78.2 million, a decrease of 26% compared to the same period in 2024. Adjusted EBITDAX was $218.8 million, down 10% year-over-year. Total production increased by 11% to 100.5...
2025-10-29MYRG8-KMYR Group Inc. Announces Third-Quarter and First Nine-Months 2025 Financial ResultsearningsHIGH
MYR Group Inc. reported its financial results for the third quarter and first nine months of 2025. The company achieved quarterly revenues of $950.4 million, a record quarterly net income of $32.1 million, and a record quarterly EBITDA of $62.7 million. The backlog as of September 30, 2025, stood at $2.66 billion. The ...
2025-10-29MVBF8-KMVB Financial Corp. Q3 2025 Earnings ReleaseearningsMEDIUM
MVB Financial Corp. (NASDAQ: MVBF) reported its financial results for the third quarter of 2025, with net income of $17.1 million, or $1.36 per basic share. Key highlights include the sale of Victor Technologies, which generated a pre-tax gain of $34.1 million, and a securities repositioning expected to add $0.30 to $0...
2025-10-29MNRO8-KMonro, Inc. Announces Second Quarter Fiscal 2026 Financial ResultsearningsMEDIUM
Monro, Inc. reported its financial results for the second quarter of fiscal 2026, ending September 27, 2025. The company saw a 1.1% increase in comparable store sales, driven by growth in front end/shocks and brakes, while tires and maintenance services remained flat. However, overall sales decreased by 4.1% to $288.9 ...
2025-10-29MDXG8-KMiMedx Group, Inc. Q3 2025 Earnings Release and Financial ResultsearningsHIGH
MiMedx Group, Inc. announced its financial results for the third quarter of 2025, reporting record net sales of $114 million, a 35% increase year-over-year. The growth was driven by a 40% increase in Wound product sales and a 26% increase in Surgical product sales. The company achieved a GAAP net income of $17 million ...
2025-10-29MAA8-KMid-America Apartment Communities Q3 2025 Earnings ReleaseearningsMEDIUM
Mid-America Apartment Communities, Inc. (MAA) reported its third quarter 2025 financial results, highlighting a diluted earnings per share of $0.84, compared to $0.98 in the same period last year. Core FFO per diluted share was $2.16, slightly down from $2.21 in Q3 2024. The company achieved a Same Store effective blen...
2025-10-29MSFT8-KMicrosoft Q1 2026 Financial Results and OpenAI Partnership UpdateearningsHIGH
Microsoft Corporation reported its financial results for the first quarter of fiscal year 2026, ending September 30, 2025. The company announced revenue of $77.7 billion, an 18% increase year-over-year, and operating income of $38.0 billion, up 24%. Net income on a GAAP basis was $27.7 billion, a 12% increase, while no...
2025-10-29MGPI8-KMGP Ingredients Q3 2025 Financial ResultsearningsMEDIUM
MGP Ingredients, Inc. reported its financial results for the third quarter of 2025, ending September 30, 2025. The company announced a 19% decrease in consolidated sales to $130.9 million compared to the same period in 2024. Gross profit declined by 25% to $49.4 million, with a gross margin decrease of 300 basis points...
2025-10-29MGM8-KMGM Resorts International Secures JPY45.2 Billion Term Loan Facilitydebt financingMEDIUM
On October 23, 2025, MGM Resorts International entered into a secured credit agreement for a term loan facility of JPY45.2 billion, with an option to increase the aggregate amount up to JPY67.8 billion. The loan bears interest at a fluctuating rate based on the Tokyo Interbank Offered Rate plus 1.75% until March 31, 20...
2025-10-29MTG8-KMGIC Investment Corporation Q3 2025 Earnings ReleaseearningsMEDIUM
MGIC Investment Corporation reported its third quarter 2025 financial results, announcing a net income of $191.1 million, or $0.83 per diluted share. Adjusted net operating income was $190.8 million, or $0.83 per diluted share. The company highlighted strong financial performance, driven by effective risk and capital m...
2025-10-29MELI8-KMercadoLibre Q3 2025 Earnings ReleaseearningsHIGH
MercadoLibre, Inc. reported its financial results for the third quarter ended September 30, 2025. The company achieved net revenues and financial income of $7.409 billion, a 39% year-over-year increase. Income from operations was $724 million, with a 9.8% margin, and net income reached $421 million, with a 5.7% margin....
2025-10-29MFIN8-KMedallion Financial Corp. Reports 2025 Third Quarter ResultsearningsMEDIUM
Medallion Financial Corp. announced its financial results for the third quarter ended September 30, 2025. The company reported a total net income attributable to stockholders of $7.8 million, or $0.32 per share, which includes a non-recurring charge of $3.5 million related to the redemption of Medallion Bank's series F...
2025-10-29MTRN8-KMaterion Corporation Reports Strong Third Quarter 2025 Financial ResultsearningsHIGH
Materion Corporation (NYSE: MTRN) announced its third-quarter 2025 financial results, reporting net sales of $444.8 million and net income of $25.4 million, or $1.22 per diluted share. The company achieved an operating profit of $34.9 million and adjusted EBITDA of $55.5 million. Key highlights include record EBITDA ma...
2025-10-29MAS8-KMasco Corporation Q3 2025 Earnings ReleaseearningsHIGH
Masco Corporation reported its third quarter 2025 financial results, showing a 3% decrease in net sales to $1,917 million compared to the same period in 2024. The company's operating profit margin declined by 220 basis points to 15.8%, while adjusted operating profit margin decreased by 190 basis points to 16.3%. Earni...
2025-10-29MKL8-KMarkel Group Inc. Q3 2025 Financial Results and Reporting ChangesearningsHIGH
Markel Group Inc. reported its financial results for the third quarter of 2025, highlighting a 7% increase in operating revenues for the quarter and a 4% year-to-date increase. The company also announced significant changes to its financial reporting, including the re-segmentation of its businesses, the expansion of co...
2025-10-29MGRX8-KMangoceuticals, Inc. Enters into Lease Agreement and Separation Agreementoperation relatedMEDIUM
Mangoceuticals, Inc. (the 'Company') has entered into a Lease Agreement with SVHQ, LLC to lease approximately 2,467 square feet of office space in Dallas, Texas, with a term of 60 months commencing on November 1, 2025. The monthly base rent is $4,852, with additional rent for real estate taxes, insurance, and maintenan...
2025-10-29FWONA8-KJohn C. Malone to Transition to Chairman Emeritus of Liberty Media Corporationofficer / director changeMEDIUM
Liberty Media Corporation announced that John C. Malone, the long-standing Chairman of the Board, will step down from the board of directors and transition to the role of Chairman Emeritus effective January 1, 2026. Robert R. Bennett, the current Vice Chairman, will assume the role of Chairman of the Board. Malone expr...
2025-10-29LILAK8-KLiberty Latin America Schedules Investor Call for Q3 2025 ResultsearningsMEDIUM
Liberty Latin America Ltd. announced plans to release its third quarter 2025 results on November 5, 2025, after the NASDAQ market close. The company will host an investor call on November 6, 2025, at 9:00 a.m. Eastern Time. During the call, management will discuss the company’s results and business, and may provide for...
2025-10-29LBTYK8-KDr. John C. Malone to Transition to Chairman Emeritus of Liberty Global Ltd.officer / director changeMEDIUM
Liberty Global Ltd. announced that Dr. John C. Malone, Chairman of the Board, will step down effective January 1, 2026, and transition to Chairman Emeritus. In this role, Dr. Malone will continue to provide strategic counsel but will not have a formal vote on Board matters. Mike Fries, the current CEO and Vice Chairman...
2025-10-29DRS8-KCEO Transition and Leadership Changes at Leonardo DRS, Inc.officer / director changeMEDIUM
Leonardo DRS, Inc. announced the retirement of William J. Lynn III as Chief Executive Officer, Non-Proxy Holder Director, and Chairman of the Board, effective December 31, 2025. Lynn will continue as an employee until April 1, 2026. Concurrently, the Board appointed John Baylouny as President and Chief Executive Office...
2025-10-29DRS8-KLeonardo DRS Q3 2025 Financial ResultsearningsHIGH
Leonardo DRS, Inc. reported its financial results for the third quarter of 2025, showing significant growth across key metrics. Revenue increased by 18% year-over-year to $960 million, driven by strong performance in counter UAS, electric power and propulsion, naval network computing, and advanced infrared sensing prog...
2025-10-29LXU8-KLSB Industries, Inc. Reports Strong Third Quarter 2025 ResultsearningsHIGH
LSB Industries, Inc. announced its financial results for the third quarter ended September 30, 2025. The company reported net sales of $155.4 million, a significant increase from $109.2 million in the same period last year. Net income for the quarter was $7.1 million, compared to a net loss of $25.4 million in the thir...
2025-10-29LFUS8-KLittelfuse Q3 2025 Earnings Release and Basler Electric AcquisitionearningsHIGH
Littelfuse, Inc. reported its financial results for the third quarter of 2025, highlighting a 10% year-over-year revenue growth to $625 million. The company achieved a GAAP diluted earnings per share (EPS) of $2.77, a 19% increase from the previous year, and an adjusted diluted EPS of $2.95, up 9%. The adjusted EBITDA ...
2025-10-29LARK8-KLandmark Bancorp, Inc. Announces Third Quarter 2025 Earnings and Declares DividendsearningsMEDIUM
Landmark Bancorp, Inc. reported its financial results for the third quarter of 2025, with diluted earnings per share of $0.85, compared to $0.75 in the previous quarter and $0.68 in the same quarter of the prior year. Net earnings for the quarter totaled $4.9 million, up from $4.4 million in the prior quarter and $3.9 ...
2025-10-29KYTX8-KKyverna Therapeutics Announces Positive Interim Phase 2 Data for KYV-101 in Generalized Myasthenia Gravisoperation relatedHIGH
Kyverna Therapeutics, Inc. reported positive interim data from the Phase 2 portion of its KYSA-6 Phase 2/3 trial of KYV-101 in generalized myasthenia gravis (gMG). The data showed robust, rapid, and sustained reductions in disease activity scores, with 100% of patients achieving clinically meaningful responses. The tre...